ArticleJTO clinical and research reports2023

First Report of Management of Sequential Small Cell Transformation and ALK I1171T Mutation as Resistance Mechanisms in a Patient With ALK-EML4 Fused Non-Small Cell Lung Adenocarcinoma With a Novel Combination of Temozolomide and Lorlatinib: A Case Report.

Umair Majeed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.